Association of Insulin-like Growth Factor-1 with Bone Mineral Density in Survivors of Childhood Acute Leukemia

被引:2
作者
Kim, Seulki [1 ]
Yoo, Jae Won [1 ]
Lee, Jae Wook [1 ]
Jung, Min Ho [1 ]
Cho, Bin [1 ]
Suh, Byng-Kyu [1 ]
Ahn, Moon Bae [1 ]
Chung, Nack-Gyun [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Pediat, Seoul 06591, South Korea
关键词
acute leukemia; bone mineral density; insulin-like growth factor-1; vertebral fracture; PEDIATRIC REFERENCE INTERVALS; HORMONE TREATMENT; BODY-COMPOSITION; BISPHOSPHONATE THERAPY; REFERENCE VALUES; KOREAN CHILDREN; SHORT-TERM; METABOLISM; FRACTURE; OSTEOPOROSIS;
D O I
10.3390/cancers16071296
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary This study investigated bone mineral deficits in children who survived childhood acute leukemia and analyzed the association of the insulin-like growth factor-1 (IGF-1) level with bone mineral density (BMD) status. Among 214 enrolled patients, 15% showed a low BMD with significant differences in IGF-1 levels. Higher IGF-1 levels were associated with a lower risk of low BMD, suggesting its potential as a valuable tool for assessing osteoporosis in survivors of childhood acute leukemia.Abstract In this study, we investigated bone mineral deficits in children who survived childhood acute leukemia and explored the association between the insulin-like growth factor-1 (IGF-1) level and bone mineral density (BMD). This retrospective analysis enrolled 214 patients treated for acute leukemia, measuring various factors including height, weight, body mass index (BMI), and lumbar spine BMD after the end of treatment. The study found an overall prevalence of low BMD in 15% of participants. Notably, IGF-1 levels were significantly different between patients with low BMD and those with normal BMD, and correlation analyses revealed associations of the IGF-1 level and BMI with lumbar spine BMD. Regression analyses further supported this relationship, suggesting that higher IGF-1 levels were associated with a decreased risk of low BMD. The study findings suggest that IGF-1 may serve as a valuable tool for evaluating and predicting osteoporosis in survivors of childhood acute leukemia.
引用
收藏
页数:11
相关论文
共 45 条
[41]   The clinical utility of bone marker measurements in osteoporosis [J].
Wheater, Gillian ;
Elshahaly, Mohsen ;
Tuck, Stephen P. ;
Datta, Harish K. ;
van Laar, Jacob M. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
[42]   Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis [J].
Wuster, C ;
Harle, U ;
Rehn, U ;
Muller, C ;
Knauf, K ;
Koppler, D ;
Schwabe, C ;
Ziegler, R .
GROWTH HORMONE & IGF RESEARCH, 1998, 8 :87-94
[43]   Pediatric reference intervals for bone markers [J].
Yang, Liju ;
Grey, Vijaylaxmi .
CLINICAL BIOCHEMISTRY, 2006, 39 (06) :561-568
[44]   Reference values for bone mineral density according to age with body size adjustment in Korean children and adolescents [J].
Yi, Kyung Hee ;
Hwang, Jin Soon ;
Kim, Eun Young ;
Lee, Jun Ah ;
Kim, Dong Ho ;
Lim, Jung Sub .
JOURNAL OF BONE AND MINERAL METABOLISM, 2014, 32 (03) :281-289
[45]   Insulin-like Growth Factor-1, Bone Mineral Density, and Fracture: A Mendelian Randomization Study [J].
Yuan, Shuai ;
Wan, Zi-Hao ;
Cheng, Shi-Le ;
Michaelsson, Karl ;
Larsson, Susanna C. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (04) :E1552-E1558